Why Braves should be eyeing Blue Jays depth in the wake of Profar's PED suspension
Briefly

Why Braves should be eyeing Blue Jays depth in the wake of Profar's PED suspension
"Jurickson Profar's second PED suspension will cost him the 2026 season - but not the $15 million he's owed in 2027. The real issue with MLB's drug policy might not be the testing. It's the contracts."
"While losing Profar ostensibly means the Braves are now down their starting left fielder, they did sign Mike Yastrzemski over the offseason. He can capably fill in there if needed. Their bigger need may just be offense in general; they lost their designated hitter (Marcell Ozuna) in free agency, leaving a slugger-sized hole in the middle of the lineup."
The Atlanta Braves face a major setback as outfielder Jurickson Profar receives a 162-game suspension for violating MLB's drug prevention and treatment program, marking his second PED violation. This suspension will sideline him for the entire 2026 season while he remains owed $15 million in 2027. The Braves are simultaneously managing injuries to catcher Sean Murphy and shortstop Ha-Seong Kim. To address the loss of their starting left fielder, the team has Mike Yastrzemski available to fill the position. The Braves' more pressing need is offensive production, particularly after losing designated hitter Marcell Ozuna in free agency. The Toronto Blue Jays present a potential trade partner, with depth players available despite losing Anthony Santander to shoulder surgery.
Read at Jays Journal
Unable to calculate read time
[
|
]